These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 17682561)
1. Survivin expression correlates with unfavourable prognoses in invasive ductal carcinoma of the breast. Al-Joudi FS; Iskandar ZA; Imran AK Med J Malaysia; 2007 Mar; 62(1):6-8. PubMed ID: 17682561 [TBL] [Abstract][Full Text] [Related]
2. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820 [TBL] [Abstract][Full Text] [Related]
3. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Barnes N; Haywood P; Flint P; Knox WF; Bundred NJ Br J Cancer; 2006 Jan; 94(2):253-8. PubMed ID: 16421596 [TBL] [Abstract][Full Text] [Related]
4. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2. Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543 [TBL] [Abstract][Full Text] [Related]
5. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972 [TBL] [Abstract][Full Text] [Related]
6. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. Kleinberg L; Flørenes VA; Nesland JM; Davidson B Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312 [TBL] [Abstract][Full Text] [Related]
7. Survivin expression predicts early recurrence in early-stage breast cancer. Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451 [TBL] [Abstract][Full Text] [Related]
8. Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast. Al-Joudi FS; Iskandar ZA; Imran AK Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):904-10. PubMed ID: 18041310 [TBL] [Abstract][Full Text] [Related]
9. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma. Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy. Boidot R; Vegran F; Lizard-Nacol S Int J Mol Med; 2009 Feb; 23(2):285-91. PubMed ID: 19148555 [TBL] [Abstract][Full Text] [Related]
11. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy. Suzuki Y; Oka K; Yoshida D; Shirai K; Ohno T; Kato S; Tsujii H; Nakano T Gynecol Oncol; 2007 Mar; 104(3):642-6. PubMed ID: 17141299 [TBL] [Abstract][Full Text] [Related]
12. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer. Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to survivin in the sera of patients with infiltrating ductal carcinoma of the breast. Al-Joudi FS; Iskandar ZA Med J Malaysia; 2006 Aug; 61(3):302-6. PubMed ID: 17240580 [TBL] [Abstract][Full Text] [Related]
14. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482 [TBL] [Abstract][Full Text] [Related]
15. High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Span PN; Tjan-Heijnen VC; Manders P; van Tienoven D; Lehr J; Sweep FC Breast Cancer Res Treat; 2006 Jul; 98(2):223-30. PubMed ID: 16541327 [TBL] [Abstract][Full Text] [Related]
16. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia. Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600 [TBL] [Abstract][Full Text] [Related]
17. Survivin and COX-2 expression in male breast carcinoma. Younis T; Haché KD; Rayson D; Dewar R; Gray S; Barnes PJ Breast; 2009 Aug; 18(4):228-32. PubMed ID: 19632843 [TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300 [TBL] [Abstract][Full Text] [Related]
19. Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy. Weiss C; von Römer F; Capalbo G; Ott OJ; Wittlinger M; Krause SF; Sauer R; Rödel C; Rödel F Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1455-60. PubMed ID: 19231102 [TBL] [Abstract][Full Text] [Related]
20. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]